Research & Literature

Soft tissue sarcoma and radiation therapy advances, impact on toxicity.

El-Bared N, Wong P, Wang D

Current treatment options in oncology 2015; (16(5)):19 doi:10.1007/s11864-015-0335-7.

Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions.

Bauer S, Joensuu H

Drugs 2015; (75(12)):1323-34 doi:10.1007/s40265-015-0440-8.

The importance of surgical margins in retroperitoneal sarcoma.

Kirane A, Crago AM

Journal of surgical oncology 2016; (113(3)):270-6 doi:10.1002/jso.24135.

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

Schöffski P, Chawla S, Maki RG, et al.

Lancet (London, England) 2016; (387(10028)):1629-37.

Synovial sarcoma presenting as a lung mass and diagnosed by cytology.

Pyden AD, Lin X

Diagnostic cytopathology 2016; (44(5)):434-7 doi:10.1002/dc.23446.

A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma.

Colosia A, Khan S, Hackshaw MD, et al.

Sarcoma 2016; (2016()):3597609 doi:10.1155/2016/3597609.

Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

Mariño-Enríquez A, Bovée JV

Surgical pathology clinics 2016; (9(3)):457-73.

Liposarcoma: Multimodality Management and Future Targeted Therapies.

Crago AM, Dickson MA

Surgical oncology clinics of North America 2016; (25(4)):761-73.

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

Ryan CW, Merimsky O, Agulnik M, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(32)):3898-3905 doi:10.1200/JCO.2016.67.6684.

Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas.

Noujaim J, Alam S, Thway K, Jones RL

Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 2016; (37(3)):125-30 doi:10.4103/0971-5851.190359.

Recent advances in the management of liposarcoma.

Nassif NA, Tseng W, Borges C, et al.

F1000Research 2016; (5()):2907 doi:10.12688/f1000research.10050.1.

Leiomyosarcoma FNCLCC G3 pT2B of broad ligament adherent to right oviduct - case report with molecular profiling.

Wincewicz A, Kowalik A, Zięba S, et al.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2016; (57(4)):1409-1414.

Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wall.

Zhao R, Yu X, Feng Y, et al.

Asia-Pacific journal of clinical oncology 2018; (14(2)):e109-e115 doi:10.1111/ajco.12807.

Differentiating and Categorizing of Liposarcoma and Synovial Sarcoma Neoplasms by Fluorescence in Situ Hybridization.

Shahi F, Alishahi R, Pashaiefar H, et al.

Iranian journal of pathology 2017; (12(3)):209-217.

Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy.

Ezuddin NS, Pretell-Mazzini J, Yechieli RL, et al.

Skeletal radiology 2018; (47(12)):1595-1606 doi:10.1007/s00256-018-2965-x.

Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.

Schliemann C, Kerkhoff A, Hesse P, et al.

PloS one 2018; (13(5)):e0197315 doi:10.1371/journal.pone.0197315.

[Dedifferentiated liposarcoma of extremities: a clinicopathologic analysis].

Gong LH, Liu WF, Ding Y, et al.

Zhonghua bing li xue za zhi = Chinese journal of pathology 2018; (47(7)):511-516 doi:10.3760/cma.j.issn.0529-5807.2018.07.006.

Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update.

Schaefer IM, Hornick JL

Advances in anatomic pathology 2018; (25(6)):400-412 doi:10.1097/PAP.0000000000000204.

Dedifferentiated Liposarcoma With Myofibroblastic Differentiation.

Wang GY, Lucas DR

Archives of pathology & laboratory medicine 2018; (142(10)):1159-1163 doi:10.5858/arpa.2018-0205-RA.

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).

Martin-Broto J, Hindi N, Cruz J, et al.

The oncologist 2019; (24(6)):e338-e346 doi:10.1634/theoncologist.2018-0121.

[Soft tissue sarcomas: limb salvage using reconstructive plastic surgery techniques].

Lehnhardt M, Sogorski A, Wallner C, et al.

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2019; (90(2)):94-101 doi:10.1007/s00104-018-0769-0.

Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?

Lazarides AL, Kerr DL, Nussbaum DP, et al.

Clinical orthopaedics and related research 2019; (477(4)):718-727 doi:10.1097/01.blo.0000533623.60399.1b.

Patient Perceptions of the Impact of Treatment (Surgery and Radiotherapy) for Soft Tissue Sarcoma.

Hewitt L, Powell R, Zenginer K, et al.

Sarcoma 2019; (2019()):9581781 doi:10.1155/2019/9581781.

Surgical resection margin classifications for high-grade pleomorphic soft tissue sarcomas of the extremity or trunk: definitions of adequate resection margins and recommendations for sampling margins from primary resection specimens.

Cates MM, Cates JMM

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019; (32(10)):1421-1433 doi:10.1038/s41379-019-0278-9.

Distinguishing bone and soft tissue infections mimicking sarcomas requires multimodal multidisciplinary team assessment.

Lex JR, Gregory J, Allen C, et al.

Annals of the Royal College of Surgeons of England 2019; (101(6)):405-410 doi:10.1308/rcsann.2019.0040.

Histopathological Spectrum of Soft-Tissue Tumors with Immunohistochemistry Correlation and FNCLCC grading: A North Indian Experience.

Singh HP, Grover S, Garg B, Sood N

Nigerian medical journal : journal of the Nigeria Medical Association 2017; (58(5)):149-155 doi:10.4103/nmj.NMJ_226_16.

Ripretinib turns off the switch in GIST.

Villanueva MT

Nature reviews. Drug discovery 2019; (18(7)):499 doi:10.1038/d41573-019-00099-4.

Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients.

Xiao W, Liang Y, Que Y, et al.

Journal of Cancer 2019; (10(15)):3517-3525 doi:10.7150/jca.28734.

Impact of unplanned resection and re-excision of a soft tissue sarcoma on prognosis.

Muñoz Muñoz P, Bajawi Carretero M, González Barranquero A, et al.

Cirugia espanola 2020; (98(5)):281-287 doi:10.1016/j.ciresp.2019.10.007.

B cells are associated with survival and immunotherapy response in sarcoma.

Petitprez F, de Reyniès A, Keung EZ, et al.

Nature 2020; (577(7791)):556-560 doi:10.1038/s41586-019-1906-8.

Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.

Wilson DAJ, Gazendam A, Visgauss J, et al.

Annals of surgical oncology 2020; (27(6)):2033-2041 doi:10.1245/s10434-020-08240-z.

Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?

Hirschmann A, van Praag VM, Haas RL, et al.

European radiology 2020; (30(9)):4724-4733 doi:10.1007/s00330-020-06810-z.

Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States.

Pollack SM, Somaiah N, Araujo DM, et al.

Cancer medicine 2020; (9(13)):4593-4602 doi:10.1002/cam4.3039.

Soft Tissue Tumors of the Extremity.

Roland CL

The Surgical clinics of North America 2020; (100(3)):669-680 doi:10.1016/j.suc.2020.02.015.

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.

Blay JY, Serrano C, Heinrich MC, et al.

The Lancet. Oncology 2020; (21(7)):923-934 doi:10.1016/S1470-2045(20)30168-6.

Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumors.

Smrke A, Gennatas S, Huang P, Jones RL

Future oncology (London, England) 2020; (16(22)):1639-1646 doi:10.2217/fon-2020-0348.

Pre- or postoperative radiotherapy for soft tissue sarcomas.

Llacer-Moscardo C, Terlizzi M, Bonvalot S, et al.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2020; (24(6-7)):501-512 doi:10.1016/j.canrad.2020.05.007.

DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma.

Scapa JV, Cloutier JM, Raghavan SS, et al.

The American journal of surgical pathology 2021; (45(2)):230-239 doi:10.1097/PAS.0000000000001564.

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.

Bonvalot S, Gronchi A, Le Péchoux C, et al.

The Lancet. Oncology 2020; (21(10)):1366-1377 doi:10.1016/S1470-2045(20)30446-0.

The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.

Choi JH, Ro JY

Advances in anatomic pathology 2021; (28(1)):44-58 doi:10.1097/PAP.0000000000000284.

The value of re-staging chest CT at first local recurrence of extremity and trunk soft tissue sarcoma.

Baig MS, Habib W, Attard V, et al.

European radiology 2021; (31(4)):2377-2383 doi:10.1007/s00330-020-07366-8.

Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy.

Du XH, Wei H, Zhang P, et al.

Frontiers in oncology 2020; (10()):564852 doi:10.3389/fonc.2020.564852.

Delayed Initiation of Treatment Is Associated With Metastasis of Soft-tissue Sarcoma.

Araki Y, Yamamoto N, Hayashi K, et al.

Anticancer research 2020; (40(12)):7009-7015 doi:10.21873/anticanres.14726.

Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma.

Gerrand C, Bate J, Seddon B, et al.

Clinical sarcoma research 2020; (10(1)):21 doi:10.1186/s13569-020-00144-6.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020).

de Juan Ferré A, Álvarez Álvarez R, Casado Herráez A, et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021; (23(5)):922-930 doi:10.1007/s12094-020-02534-0.

Sarcoma classification by DNA methylation profiling.

Koelsche C, Schrimpf D, Stichel D, et al.

Nature communications 2021; (12(1)):498 doi:10.1038/s41467-020-20603-4.

Gene Fusion Identification Using Anchor-Based Multiplex PCR and Next-Generation Sequencing.

Cheng YW, Meyer A, Jakubowski MA, et al.

The journal of applied laboratory medicine 2021; (6(4)):917-930 doi:10.1093/jalm/jfaa230.

Impact of surgical margin on survival in extremity soft tissue sarcoma: A systematic review and meta-analysis.

Jang WY, Kim HS, Han I

Medicine 2021; (100(3)):e24124 doi:10.1097/MD.0000000000024124.

Is no additional excision after unplanned excision with positive margins justified in patients with small (≤5 cm) high-grade soft-tissue sarcoma?: Analysis from the Bone and Soft Tissue Tumor registry in Japan.

Nakamura T, Kawai A, Asanuma K, et al.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2022; (27(2)):463-467 doi:10.1016/j.jos.2020.12.022.

Traveling to Receive Treatment for Extremity Soft Tissue Sarcomas: Is it worth the drive?

Vidri RJ, Raut CP, Fitzgerald TL

World journal of surgery 2021; (45(8)):2415-2425 doi:10.1007/s00268-021-06109-0.

Advances in the management of alveolar soft part sarcoma.

O'Sullivan Coyne G, Naqash AR, Sankaran H, Chen AP

Current problems in cancer 2021; (45(4)):100775 doi:10.1016/j.currproblcancer.2021.100775.

Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline.

Salerno KE, Alektiar KM, Baldini EH, et al.

Practical radiation oncology 2021; (11(5)):339-351 doi:10.1016/j.prro.2021.04.005.

Sarcomas: New Biomarkers and Therapeutic Strategies.

Nakamura T

Cancers 2021; (13(20)) doi:10.3390/cancers13205213.

[Preoperative diagnostics and typing of abdominal soft tissue sarcomas].

Kirchberg J, Blum SFU, Pablik J, et al.

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2022; (93(1)):5-15 doi:10.1007/s00104-021-01528-0.

Adult Soft-Tissue Sarcomas of the Extremities.

Bickels J, Malawer MM

The Journal of bone and joint surgery. American volume 2022; (104(4)):379-389 doi:10.2106/JBJS.21.00196.

Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.

Squires MH, Ethun CG, Donahue EE, et al.

Annals of surgical oncology 2022; (29(5)):3291-3301 doi:10.1245/s10434-021-11205-5.

Soft tissue sarcoma: Recognizing a rare disease.

Ardakani AHG, Woollard A, Ware H, Gikas P

Cleveland Clinic journal of medicine 2022; (89(2)):73-80 doi:10.3949/ccjm.89a.21078.

Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients.

Voss RK, Callegaro D, Chiang YJ, et al.

Annals of surgical oncology 2022; doi:10.1245/s10434-022-11442-2.

Impact of the KIT/PDGFRA genotype on prognosis in imatinib-naïve Japanese patients with gastrointestinal stromal tumor.

Cho H, Nishida T, Takahashi T, et al.

Annals of gastroenterological surgery 2022; (6(2)):241-248 doi:10.1002/ags3.12527.

Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study.

Ebrahimpour A, Chehrassan M, Sadighi M, et al.

The archives of bone and joint surgery 2022; (10(1)):67-77 doi:10.22038/ABJS.2021.53750.2676.

Musculoskeletal Metastasis From Soft-tissue Sarcomas: A Review of the Literature.

Pretell-Mazzini J, Seldon CS, D'Amato G, Subhawong TK

The Journal of the American Academy of Orthopaedic Surgeons 2022; (30(11)):493-503 doi:10.5435/JAAOS-D-21-00944.

Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas-Looking Forward.

Istl AC, Gronchi A

Cancers 2022; (14(7)) doi:10.3390/cancers14071831.

Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.

Callegaro D, Raut CP, Ajayi T, et al.

Annals of surgery 2023; (278(1)):127-134 doi:10.1097/SLA.0000000000005492.

Experience with second-line trabectedin in daily clinical practice: case studies.

Martín-Broto J, Hindi N, Grignani G, et al.

Future oncology (London, England) 2022; (18(30s)):23-32 doi:10.2217/fon-2022-0519.

Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma.

Potkrajcic V, Kolbenschlag J, Sachsenmaier S, et al.

Radiation oncology (London, England) 2022; (17(1)):210 doi:10.1186/s13014-022-02166-4.

The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).

Sparber-Sauer M, Ferrari A, Spunt SL, et al.

Cancer medicine 2023; (12(10)):11719-11730 doi:10.1002/cam4.5671.

Amputation surgery associated with shortened survival in patients with localized soft tissue sarcoma.

Matsuoka M, Onodera T, Yokota I, et al.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2024; (29(2)):637-645 doi:10.1016/j.jos.2023.02.024.

Outcome of Surgery as Part of Palliative Care of Patients with Symptomatic Advanced or Metastatic Extra-Abdominal High-Grade Soft Tissue Sarcoma.

Farzaliyev F, Steinau HU, Ring A, et al.

Palliative medicine reports 2023; (3(1)):64-70 doi:10.1089/pmr.2022.0063.

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.

Fazel M, Dufresne A, Vanacker H, et al.

Cancers 2023; (15(6)) doi:10.3390/cancers15061643.

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.

Heater NK, Okuno S, Robinson S, et al.

Journal of clinical medicine 2023; (12(7)) doi:10.3390/jcm12072561.

Intrathoracic synovial sarcoma with BRAF V600E mutation.

Russo I, Barresi S, Di Paolo PL, et al.

Oncotarget 2023; (14()):703-708 doi:10.18632/oncotarget.28475.

Local recurrence management of extremity soft tissue sarcoma.

Serban B, Cretu B, Cursaru A, et al.

EFORT open reviews 2023; (8(8)):606-614 doi:10.1530/EOR-23-0095.

New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter.

Callegaro D, Barretta F, Raut CP, et al.

Annals of surgery 2024; (279(5)):857-865 doi:10.1097/SLA.0000000000006098.

Does compartmental resection really impact retroperitoneal soft tissue sarcomas? A retrospective analysis from a Single Referral Center.

Garcia-Ortega DY, Ortega Jiménez JA, Melendez-Fernandez AP, et al.

Surgical oncology 2023; (51()):101997 doi:10.1016/j.suronc.2023.101997.

Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review.

Assi T, Ngo C, Faron M, et al.

Current treatment options in oncology 2023; (24(11)):1598-1613 doi:10.1007/s11864-023-01139-3.

Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.

Kokkali S, Georgaki E, Mandrakis G, et al.

Cells 2023; (12(22)) doi:10.3390/cells12222632.

Evaluation of the factors affecting survival and local recurrence in thigh soft tissue sarcomas.

Yıldırım S, Çiftdemir M, Ustabaşıoğlu FE, et al.

Joint diseases and related surgery 2024; (35(1)):130-137.

Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?-A Systematic Review and Meta-Analysis.

Larios F, Gonzalez MR, Ruiz-Arellanos K, et al.

Cancers 2024; (16(2)) doi:10.3390/cancers16020443.

Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.

Sugita S, Tanaka K, Oda Y, et al.

Japanese journal of clinical oncology 2024; (54(6)):675-680 doi:10.1093/jjco/hyae020.

Clinical and surgical effectiveness of the multi-disciplinary standardized management model in the treatment of retroperitoneal liposarcoma: Evidence-based clinical practice experience from Fudan Zhongshan.

Fan P, Tao P, Wang J, et al.

Surgery 2024; (175(5)):1368-1376 doi:10.1016/j.surg.2024.01.012.

Assessment of local complications with preoperative versus postoperative radiotherapy in patients with soft tissue sarcoma in extremities: A randomized comparative clinical trial.

Abdallah ZK, El Masry AM, Azmy SI, et al.

Journal of orthopaedics 2024; (53()):34-40 doi:10.1016/j.jor.2024.02.042.

The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study.

Nakamura T, Takenaka S, Outani H, et al.

Cancers 2024; (16(5)) doi:10.3390/cancers16051077.

Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma.

Roohani S, Wiltink LM, Kaul D, et al.

Current treatment options in oncology 2024; (25(4)):543-555 doi:10.1007/s11864-024-01188-2.

Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma.

Guadagnolo BA, Baldini EH

Seminars in radiation oncology 2024; (34(2)):180-194 doi:10.1016/j.semradonc.2023.12.003.

The devastating impact of unresectable infectious undifferentiated pleomorphic sarcoma in the gluteal region: A case report.

Goli R, Torabzadeh A, Hassanpour A, et al.

International journal of surgery case reports 2024; (118()):109592 doi:10.1016/j.ijscr.2024.109592.

A Case Report of Malignant Mesenchymal Tumor Presenting As Anterior Thigh Swelling: A Diagnostic Challenge.

Rey J, Shukla S, Acharya S, et al.

Cureus 2024; (16(3)):e55669 doi:10.7759/cureus.55669.

UK guidelines for the management of soft tissue sarcomas.

Hayes AJ, Nixon IF, Strauss DC, et al.

British journal of cancer 2025; (132(1)):11-31 doi:10.1038/s41416-024-02674-y.

MDM2 amplification in rod-shaped chromosomes provides clues to early stages of circularized gene amplification in liposarcoma.

Sydow S, Piccinelli P, Mitra S, et al.

Communications biology 2024; (7(1)):606 doi:10.1038/s42003-024-06307-1.

Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy.

Mangone L, Marinelli F, Bisceglia I, et al.

Cancers 2024; (16(13)) doi:10.3390/cancers16132390.

Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS).

Mata Fernández C, Sebio A, Orcajo Rincón J, et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025; (27(3)):824-836 doi:10.1007/s12094-024-03602-5.

Mapping the Course of Recovery Following Limb-Salvage Surgery for Soft-Tissue Sarcoma of the Extremities.

Lazarides AL, Burke ZDC, Gundavda MK, et al.

The Journal of bone and joint surgery. American volume 2024; (106(19)):1797-1808 doi:10.2106/JBJS.23.01007.

Beyond Clinical Examination: Utilizing MRI Surveillance to Detect Recurrence of Soft Tissue Sarcomas and Differentiate from Posttherapeutic Changes.

Koenig FRM, Kielburg AH, Chaudhary SR, et al.

Biomedicines 2024; (12(8)) doi:10.3390/biomedicines12081640.

Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma.

Pautier P, Italiano A, Piperno-Neumann S, et al.

The New England journal of medicine 2024; (391(9)):789-799 doi:10.1056/NEJMoa2403394.

Survival and prognostic factors among different types of liposarcomas based on SEER database.

Zhao J, Du W, Tao X, et al.

Scientific reports 2025; (15(1)):1790 doi:10.1038/s41598-025-85937-9.

The Impact of Surgical Margin Distance on Local Recurrence and Survival in Patients with Soft Tissue Sarcoma.

Yurtbay A, Aydın Şimşek Ş, Cengiz T, et al.

Medicina (Kaunas, Lithuania) 2025; (61(2)) doi:10.3390/medicina61020289.

[Localized soft tissue sarcomas].

Hettler M, Jakob J

Chirurgie (Heidelberg, Germany) 2025; (96(6)):524-534 doi:10.1007/s00104-025-02267-2.

Global burden of soft tissue sarcomas in 204 countries and territories from 1990 to 2021: data from the global burden of disease study 2021.

Zhou J, Xu S, Long Y, et al.

BMC public health 2025; (25(1)):1519 doi:10.1186/s12889-025-22782-5.

ASO Practice Guidelines Series: Multidisciplinary Management of Retroperitoneal Sarcomas.

Sarre Lazcano C, Cardona K, Callegaro D

Annals of surgical oncology 2025; (32(7)):5343-5355 doi:10.1245/s10434-025-17284-y.

Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with gastrointestinal stromal tumor and D842V-PDGFRA mutation.

Nuñez Hernández I, Gómez Palmero C, Delgado JR, et al.

The oncologist 2025; (30(5)) doi:10.1093/oncolo/oyaf062.

Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease.

Cicala CM, Bauer S, Heinrich MC, Serrano C

Hematology/oncology clinics of North America 2025; (39(4)):773-784 doi:10.1016/j.hoc.2025.04.006.

Local Control in Soft Tissue Sarcomas.

Baldini EH, Gronchi A

Hematology/oncology clinics of North America 2025; (39(4)):693-708 doi:10.1016/j.hoc.2025.04.011.

Primary treated versus referred trunk and extremities soft tissue sarcomas: comparative analysis of initial treatment impact on disease control.

Nardi WS, Aragone L, Quildrian SD

Ecancermedicalscience 2025; (19()):1933 doi:10.3332/ecancer.2025.1933.

The imitation game: large language models versus multidisciplinary tumor boards: benchmarking AI against 21 sarcoma centers from the ring trial.

Li CP, Kalisa AT, Roohani S, et al.

Journal of cancer research and clinical oncology 2025; (151(9)):248 doi:10.1007/s00432-025-06304-9.

Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patients.

Eckardt MA, Siena NM, Copeland AR, et al.

Surgery 2025; (188()):109610 doi:10.1016/j.surg.2025.109610.

[Therapeutic strategy for soft tissue tumors and peripheral sarcomas in adults].

Bonvalot S, Binder JP, Darrigues L, et al.

Annales de chirurgie plastique et esthetique 2025; (70(6)):590-597 doi:10.1016/j.anplas.2025.05.008.

[Resection of soft tissue sarcomas on the thigh].

Niethard M, Mahr D, Geis S

Operative Orthopadie und Traumatologie 2026; (38(1)):11-22 doi:10.1007/s00064-025-00924-7.

Biphasic Synovial Sarcoma With Neuroendocrine Differentiation: A Case Report.

Phillipow N, Hong B, Vanderbeck K

The American Journal of dermatopathology 2026; (48(4)):289-293 doi:10.1097/DAD.0000000000003217.

PATIENTS WITH SOFT TISSUE SARCOMA AFTER TREATMENT BY NON ORTHOPEDIC ONCOLOGIC SURGEONS: EPIDEMIOLOGICAL PROFILE, STAGING, AND THERAPEUTIC CHALLENGES.

do Couto FB, Yonamine ES, Magno FG, et al.

Acta ortopedica brasileira 2026; (34(1)):e293900 doi:10.1590/1413-785220263401e293900.

Clinical Impact of Integrating RNA-Based Next-Generation Sequencing Into the Diagnostic Evaluation of Soft Tissue Sarcomas: Insights From a Single-Center Multidisciplinary Workflow.

Sreenath ND, Singh K, Rastogi S, et al.

JCO global oncology 2026; (12(3)):e2500440 doi:10.1200/GO-25-00440.